Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
2 clinical trials · Condition
◉ Watch Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
| Record | Firm | Date |
|---|---|---|
| Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site (NCT05110781) | University of California, Davis | 2021-12-07 |
| Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery (NCT03565783) | M.D. Anderson Cancer Center | 2018-07-03 |
Track Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck automatically
Every clearance here is in the API, with alerts when new ones post.